Skip to Content Facebook Feature Image

5th Hospitality Japan Conference #HJC2026 Set to Unpack Capital Strategy, Design, and Margin Protection in Tokyo

Business

5th Hospitality Japan Conference #HJC2026 Set to Unpack Capital Strategy, Design, and Margin Protection in Tokyo
Business

Business

5th Hospitality Japan Conference #HJC2026 Set to Unpack Capital Strategy, Design, and Margin Protection in Tokyo

2026-08-13 09:39 Last Updated At:09:55

Asia-Pacific's premier hospitality gathering returns October 6–7, 2026, bringing together over 350 industry leaders to navigate Japan's JPY 630 billion market transformation.

TOKYO, Aug. 13, 2026 /PRNewswire/ -- Japan's hotel sector is entering a new operational phase. One shaped by changing guest expectations, evolving investment flows, and a heightened focus on distinct, experience-led design. Scheduled to take place on October 6–7, 2026, at The Capitol Hotel Tokyu in Tokyo, 5th Hospitality Japan Conference #HJC2026, organized by Hospitality Asia, is a premier two-day leadership assembly that will gather the nation's foremost asset owners, operators, developers, and tech visionaries under the country theme: "Redefining Hospitality: Strategic Insights Beyond Borders in Japan."

Aligned with the Hospitality Asia regional mandate, "Leading Hospitality Forward: Investing in Design, Driving Results," #HJC2026 steps away from broad macro-generalities to focus heavily on grounded execution and calculated risk to unlock new performance benchmarks. Spanning two days, the event expands into three focused, co-located summits offering an institutional deep dive into capital strategy, spatial identity, and revenue performance across Japan's unique operating landscape:

Day 1: Capital Allocation & Spatial Performance Systems

Hotel Investment Summit Japan (#HISJ): Focuses on institutional capital allocations, leveraged returns, M&A structuring, and contractual power dynamics.

In 2026, Japan's hospitality sector stands as the undisputed heavyweight of the Asia-Pacific real estate market, with hotel transaction volumes reaching a liquid JPY 630 billion and 69% of investors projecting investment NOI to be in a recovery phase. HISJ bypasses generic updates to put cross-border PE leads, J-REIT CIOs, and asset owners face-to-face to navigate the BOJ's policy interest rate normalization (1.0%–1.25%), compressed central Tokyo net yields (1.0%–1.8%), and escalating construction costs (+5.0% to 5.6% annually).

HISJ's core discussions center on four strategic boardroom pillars: evaluating optimal capital structures and credit-rated bond pricing against rising debt costs; navigating central Tokyo land scarcity while capitalizing on regional whitespace like Nagoya and Tohoku; dissecting the asymmetric resort economics of Niseko and Okinawa co-developments; and auditing HMA fee erosion, early contract terminations, and outbound expansion by domestic operators deploying asset-light models into global markets.

Hotel Design Summit Japan (#HDSJ):

Centering on "Designing Hotels That Perform: Where Design, Tech, and Asset Value Converge," HDSJ positions design as a strategic discipline that directly influences asset performance, operational efficiency, and long-term investment value. Architects, interior designers, developers, and tech innovators convene to examine how spatial identity connects space, culture, sustainability, and human experience into measurable, high-yield outcomes amidst rising construction costs and labor shortages.

The summit's agenda examines the evolution of design as a revenue-generating asset, the integration of AI, automation, and smart building systems, and the rise of hyperlocal, culturally embedded luxury hospitality alongside human-centric wellness environments. Discussions will further explore the adoption of sustainable, timber-based, and low-carbon construction methods, the rapid growth of adaptive reuse and heritage-led hotel development, and the seamless convergence of architecture, interiors, lighting, and experience design.

Day 2: Profitability & Commercial Strategy in the Era of 60 Million Visitors

Hotel Revenue Summit Japan (#HRSJ):

Focuses on "Beyond the Top Line: Strategies for Margin Protection in the Era of 60 Million Visitors." While record inbound tourism and sustained ADR growth fuel strong fundamentals, rising labor costs and operating expenses are compressing margins. HRSJ gathers commercial leaders, asset managers, and revenue strategists to explore high-yield distribution pipelines, AI and automation, ancillary revenue generation, and direct booking channels built to protect net profitability.

The sessions deliver action-oriented insights covering revenue strategy and commercial excellence, distribution, loyalty, and customer acquisition, alongside labor productivity and commercial efficiency. Industry experts will also evaluate the application of artificial intelligence and revenue technology, ancillary revenue and new business models, hotel asset performance and profit optimization, and long-term risk, resilience, and value creation.

Plenary Sessions & Exhibition Showcase Featuring 40+ Sponsors & Partners

The 5th edition is expected to host 90+ expert speakers, 350+ pre-qualified delegates, and 200+ leading companies across 40+ high-impact sessions. Alongside the core plenary panel tracks, the conference features an interactive Exhibition Showcase presenting over 40 sponsors and strategic partners, combined with signature Match & Meet curated networking blocks engineered to facilitate direct project-and-capital deal-making on the event floor.

For industry stakeholders looking to safeguard their margins, scale their portfolios accurately, and build resilient assets, #HJC2026 provides the essential localized playbook to successfully navigate the next real estate cycle.

For the full event agenda, speaker listings, or to register as a delegate or sponsor, please visit the official website at https://hospitalityjapanconference.com/

PR Newswire is the Official Media Partner of the 5th Hospitality Japan Conference #HJC2026. 

For Sponsorship Enquiries, contact:
Gloria Wong
Managing Director
gloria@hospitality-asia.com

For speaking & delegate enquiries, contact:
Steven Feng
Senior Event Producer
steven@hospitality-asia.com

For partnership enquiries, contact:
Irma Maulida
Conference Producer
irma@hospitality-asia.com

Media Contact:
Hospitality Asia Media
Ifnur
ifnur@hospitality-asia.com 

About Hospitality Asia

The Hospitality Asia Event Series is a leading platform for senior leaders across the region's hospitality and tourism sectors. It is known for bringing together key decision-makers and industry innovators while creating strong opportunities for networking, knowledge exchange, and strategic collaboration.

The series features seven flagship events across Asia, including the Hospitality Indonesia Conference (HIC), the Hospitality Vietnam Conference (HVC), the Hospitality Thailand Conference (HTC), the Hospitality South Korea Conference (HSKC), the Hospitality Malaysia Conference (HMC), the Hospitality Philippines Conference (HPC) and the Hospitality Japan Conference (HJC). These events attract a high-level and diverse audience from across the region.

Hospitality Asia is distinguished by its balanced engagement of both C-level executives and senior professionals such as Vice Presidents, General Managers and Directors who manage contracts, negotiations and daily operations. Supported by regional advisors who provide real-time market insights, the content focuses on practical strategies that enable participants to drive business growth.

The series is guided by four summits that represent the main drivers of industry success. These include the Hotel Investment Summit Asia #HISA, the Hotel Design Summit Asia #HDSA, the Hotel Revenue Summit Asia #HRSA and the Travel Byte Summit Asia #TBSA. Each summit is delivered with a localized approach to ensure relevance and meaningful engagement with the region's most important opportunities.

To learn more about Hospitality Asia, please visit our website at www.hospitality-asia.com

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

5th Hospitality Japan Conference #HJC2026 Set to Unpack Capital Strategy, Design, and Margin Protection in Tokyo

5th Hospitality Japan Conference #HJC2026 Set to Unpack Capital Strategy, Design, and Margin Protection in Tokyo

Following REJURAN®'s TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals.

GANGNEUNG, South Korea, Aug. 13, 2026 /PRNewswire/ -- PharmaResearch, the biopharmaceutical company behind REJURAN®, recently participated in Aesthetics 2026, an international aesthetic medicine symposium held in Sydney, Australia. The company delivered scientific presentations and clinical education programs focused on its flagship polynucleotide (PN)-based skin booster.

Aesthetics 2026 brings together dermatologists, plastic surgeons and aesthetic medicine professionals from across Australia to share clinical insights and discuss the latest advances in the field. Convened by internationally recognized plastic surgeon Dr. Steven Liew, the event has become a key forum for scientific exchange within Australia's aesthetic medicine community.

During the event, Dr. Liew expressed strong interest in REJURAN's growing body of clinical evidence and PharmaResearch's structured education programs for healthcare professionals. The discussions also covered potential future collaboration in areas such as the development of scientific content tailored to the needs of Australian patients and local clinical practice, as well as training programs for local healthcare professionals. Building on these discussions, PharmaResearch plans to expand its scientific partnerships with global key opinion leaders and foster long-term relationships with Australia's medical community.

PharmaResearch hosted scientific sessions on the clinical use of REJURAN, along with a dedicated REJURAN clinical masterclass. The sessions provided Australian healthcare professionals with case-based insights and clinical data, focusing on treatment planning and injection techniques tailored to individual patient needs and goals.

Leading Korean medical experts, including Dr. Nark-Kyoung Rho, director of Leaders Dermatology Clinic Cheongdam, and Dr. Ho Sung Choi, director of LIEUL Clinic Seoul, served as featured speakers. Drawing on cases from their own practices, they discussed individualized treatment strategies for skin barrier function, pigmentation and the periorbital area. They also shared practical guidance on applying REJURAN across a range of skin concerns and patient profiles, strengthening participants' understanding of its clinical applications.

A dedicated K-Session featuring Korean medical experts also examined the latest developments in Korean aesthetic medicine and shared insights gained from clinical practice in Korea. Moving beyond a general product introduction, the session focused on real-world treatment planning and injection techniques, further expanding scientific exchange between healthcare professionals in Korea and Australia.

"This event demonstrated REJURAN's growing presence in the global aesthetic medicine market, supported by its scientific foundation and clinical evidence," a PharmaResearch representative said. "We will continue to expand our scientific collaboration with global key opinion leaders and strengthen clinical education for Australian healthcare professionals."

REJURAN entered the Australian market in 2023 following its inclusion in the Australian Register of Therapeutic Goods as a Class III medical device. Since then, PharmaResearch has continued to provide clinical education and facilitate scientific exchange for Australian healthcare professionals, supporting the appropriate clinical use of REJURAN.

About PharmaResearch:

PharmaResearch is a pioneering biopharmaceutical company dedicated to enhancing the quality of life for humanity through regenerative medicine. Its diverse portfolio includes medicines, medical devices, cosmetics, and health supplements, all leveraging the core ingredients - DOT™ PDRN and DOT™ PN - which are protected by multiple patents. PharmaResearch is headquartered in Gangneung-si, Gangwon-do.

Learn more at https://pharmaresearch.com/en/

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN® at Aesthetics 2026

Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN® at Aesthetics 2026

Recommended Articles